New York University Langone Health Perlmutter Cancer Cancer is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
New York University Langone Health Perlmutter Cancer Cancer has participated in 1 clinical trials.
Therapeutic areas: Non-small Cell Lung Cancer.
Sponsors: Vitrac Therapeutics, LLC.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York University Langone Health Perlmutter Cancer Cancer has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York University Langone Health Perlmutter Cancer Cancer has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer.
New York University Langone Health Perlmutter Cancer Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.